Home
|
About us
|
Editorial Board
|
Search
|
Ahead of print
|
Current Issue
|
Archives
|
Instructions
|
Online submission
|
Contact Us
|
Subscribe
|
Advertise
|
Reader Login
Page layout
Official publication of Indian Chest Society
Users Online: 285
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
Citation statistics : Table of Contents
2007| April-June | Volume 24 | Issue 2
Online since
January 29, 2009
Archives
Previous Issue
Next Issue
Most popular articles
Most cited articles
Show all abstracts
Show selected abstracts
Export selected to
Cited
Viewed
PDF
CASE REPORTS
Unilateral pulmonary hypoplasia - A case report
S Kant
April-June 2007, 24(2):69-71
DOI
:10.4103/0970-2113.44215
A case of right sided pulmonary hypoplasia is described. A 20 years male was admitted in our department with complaints of recurrent chest infections since childhood. Clinical examination revealed smaller right hemithorax. Serial chest X rays showed nonprogressive lesions over several years. Bronchoscopy and CT scan thorax confirmed the diagnosis of right sided pulmonary hypoplasia. It was not associated with any other developmental anomaly.
[ABSTRACT]
[FULL TEXT]
[PDF]
[CITATIONS]
3
5,677
739
ORIGINAL ARTICLES
Multidrug resistant tuberculosis: Role of previous treatment with second line therapy on treatment outcome
R Singh, D Gothi, JM Joshi
April-June 2007, 24(2):54-57
DOI
:10.4103/0970-2113.44211
Setting:
The tuberculosis referral center of a tertiary care hospital. Objective: To determine human immunodeficiency virus (HIV) seropositivity, diabetes mellitus (DM), treatment outcome, cost, and adverse drug reaction in patients with multidrug resistance (MDR) pulmonary tuberculosis.
Design:
56 cases of MDR tuberculosis from April 2001 to April 2003 were included. Fasting blood sugar and three-step rapid immunoassay test for HIV was performed in all cases. 45/56 patients were able to arrange for second line drugs with the help of Medical Social Worker.
Results:
1/56(1.8%) and 7/56 (12.5 %) cases were positive for HIV and DM respectively. Of the 45 cases started on second line drugs, 5 (11.1%) defaulted, 9 (20%) patients died, 31 patients (68.8%)
completed
treatment of which 19 (61%) were cured and 9 (39%) failed therapy. 17/19 (89%) who were cured had never received any second line drug previously (P=0.004 i.e. less than 0.5). The cost of therapy was $1000-2000. Adverse drug effects were seen in 13/45 patients (28.8%). Conclusions: Successful outcome of therapy was associated with absence of previous treatment with one or more second line drugs. Treatment with second line drugs was expensive and toxic
[ABSTRACT]
[FULL TEXT]
[PDF]
[CITATIONS]
2
2,121
437
Study of efficacy of DOTS in pulmonary tuberculosis patients with associated diabetes
RK Kotokey, DN Bhattacharya, P Das, AK Azad, A De
April-June 2007, 24(2):58-60
DOI
:10.4103/0970-2113.44212
The present study was conducted in the Department of Medicine, Assam Medical College and Hospital, Dibrugarh for a period of one year from 1st of August 2004 to 31st July 2005 on patients of tuberculosis with associated diabetes to assess the efficacy of DOTS in pulmonary tuberculosis. Glycemic control was achieved with the use of insulin and most patients showed fair control of hyperglycemia. Though the study group lagged behind in the initial weeks all the cases and controls improved clinically at the end of 2 months. The diabetic population lagged behind in radiological improvement at the end of 3 months. Sputum conversion was achieved at the end of 3 months in all cases after giving extended treatment in the respective cases. This study showing efficacy of DOTS in pulmonary TB and Diabetes is the first of its kind in this region.
[ABSTRACT]
[FULL TEXT]
[PDF]
[CITATIONS]
2
2,349
382
Randomized controlled study of CBT in bronchial asthma
Naveen Grover, G D'Souza, K Thennarasu, V Kumaraiah
April-June 2007, 24(2):45-50
DOI
:10.4103/0970-2113.44209
The aim of the present study was to find out efficacy of cognitive behavior therapy, as an adjunct to standard pharmacotherapy, in bronchial asthma. In a randomized two-group design with pre-and post assessments, forty asthma patients were randomly allotted to two groups: self management group and cognitive behavior therapy group. Both groups were exposed to 6-8 weeks of intervention, asthma self management program and cognitive behavior therapy. Assessment measures used were-Semi structured interview schedule, Asthma Symptom Checklist, Asthma diary, Asthma Bother Profile, Hospital Anxiety & Depression Scale, AQLQ and Peak Expiratory Flow Rate. Within group comparison showed significant improvement in both groups at the post assessment. Between group comparisons showed that CBT group reported significantly greater change than that of SM group. Cognitive behavior therapy helps in improving the managment of asthma.
[ABSTRACT]
[FULL TEXT]
[PDF]
[CITATIONS]
1
3,622
530
CASE REPORTS
Reexpansion pulmonary edema- A case report
AK Janmeja, PR Mohapatra, MS Saini, A Khurana
April-June 2007, 24(2):72-74
DOI
:10.4103/0970-2113.44217
A middle aged male presented to us with right side pneumothorax. Two hours after insertion of intercostals tube he felt discomfort and increased breathlessness. His chest examination showed crepitations. Chest radiograph showed partial expansion of right lung with opacity in right lower zone consistent with unilateral pulmonary edema. He was managed conservatively and improved with complete resolution on chest radiograph. Reexpansion pulmonary edema is an uncommon complication of the treatment of lung atelectasis, pleural effusion or pneumothorax and pathogenesis is unclear.
[ABSTRACT]
[FULL TEXT]
[PDF]
-
2,231
338
Yellow nail syndrome
Ramakant Dixit, Kalpana Dixit, Savita Jindal
April-June 2007, 24(2):66-68
DOI
:10.4103/0970-2113.44214
A case of yellow nail syndrome is described in a forty year old male patient who presented with classical triad of this syndrome i.e. deformed yellow nails, lymphedema and chronic recurrent pleural effusion. The practical problems in the diagnosis are also briefly discussed with emphasis on awareness of this rare clinical entity.
[ABSTRACT]
[FULL TEXT]
[PDF]
-
3,661
294
EDITORIAL
Palliative care
Surinder K Jindal
April-June 2007, 24(2):43-44
DOI
:10.4103/0970-2113.44208
[FULL TEXT]
[PDF]
-
928
212
ORIGINAL ARTICLES
Pattern of initial drug resistance and its impact on short course chemotherapy of pulmonary tuberculosis
SP Rai, D Bhattacharyya, M Kashyap
April-June 2007, 24(2):51-53
DOI
:10.4103/0970-2113.44210
Objectives :
To find the pattern of initial drug resistance in fresh sputum culture positive cases of pulmonary tuberculosis and its impact on maintenance phase of short course chemotherapy (SCC) and treatment outcome.
Methods :
Case records of all patients of initial drug resistance treated by us between Jan 2001 to May 2004 were analyzed retrospectively. Pattern of drug resistance leading to modification of maintenance phase of anti-tubercular treatment (ATT) and treatment out-come in these patients were analyzed. After treatment all cases were followed up for a minimum of six months duration, for relapse.
Results :
Out of 769 cases of culture positive pulmonary tuberculosis , drug resistance was seen in 138 patients. Out of total 203 individual drug resistance, resistance was present to isoniazid in 22, rifampicin in 27, ethambutol in 23, streptomycin in 16, pyrazinamide in 36 and ciprofloxacin in 79 cases. Among them 5 drugs resistance was seen in 4 patients, 4 drugs resistance in 3 patients, 3 drugs resistance in 9 patients, 2 drugs resistance in 22 patients and single drug resistance in 100 patients, Multi drug resistance (MDR) was observed in 12 patients. One patient died of hemoptysis after 4 months of ATT. Four patients continued to be sputum positive even after one year of second line ATT. They were subsequently lost to follow up. All the remaining patients achieved cure and had no relapse at the end of six months follow up.
Conclusion:
This study highlights the importance of initial drug resistance in modifying maintenance phase of short course chemotherapy, thereby improving success rates and helps in preventing multidrug resistance tuberculosis.
[ABSTRACT]
[FULL TEXT]
[PDF]
-
1,861
323
REVIEW ARTICLE
Role of matrix metalloproteinases in the pathophysiology of idiopathic pulmonary fibrosis
P Bhattacharyya, D Acharya, S Roychowdhury
April-June 2007, 24(2):61-65
DOI
:10.4103/0970-2113.44213
Idiopathic pulmonary fibrosis (IPF), a progressive fibrosing lung condition is a therapeutic medical challenge. The etiopathogenesis of IPF is complicated and hitherto not adequately understood. However, the concept, of late, is shifting from fibrosis as a result of inflammation to a mechanism of primarily dysregulated fibrogenesis. A class of enzymes called matrix metallo proteinases (MMPs) appear important in the pathogenesis of IPF. The heightened activity of MMPs are derived out of an imbalance between them (MMPs) and their tissue inhibitors (TIMPs). This leads to breakdown of interstitial matrix and triggering of certain growth factors which play an important mechanistic role in the pathogenesis of IPF. Understanding of the role of MMPs in pathogenesis of IPF may open up a new horizon of therapeutic intervention of the desease.
[ABSTRACT]
[FULL TEXT]
[PDF]
-
2,284
353
Feedback
Sitemap
|
What's New
|
Feedback
|
Disclaimer
© 2008 Lung India | Published by Wolters Kluwer -
Medknow
New site online since 20
th
January 2009